Moleculin Biotech Inc

NASDAQ:MBRX   4:00:00 PM EDT
1.03
+0.05 (+5.10%)
7:19:56 PM EDT: $1.09 +0.06 (+5.83%)
Products

Moleculin Announces Annamycin Receives FDA Orphan Drug Designation For Soft Tissue Sarcomas

Published: 12/29/2020 13:05 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas.